Linzess Capsule, Gelatin Coated
Product Images NDC 0456-1203

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linzess (NDC 0456-1203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Linzess (linaclotide) Is A Guanylate Cyclase-c (g-cc) Agonist. Linaclotide Is A 14-amino Acid Peptide With The Following Chemical Name: L-cysteinyl-l-cysteinyl-l-glutamyl-l-tyrosyl-l-cysteinyl-l-cysteinyl-l-asparaginyl-l-prolyl-l-alanyl-l-cysteinyl-l-threonyl-glycyl-l-cysteinyl-l-tyrosine, Cyclic (1-6), (2-10), (5-13)-tris (disulfide). (Linzess 01)

Chemical structure diagram of linaclotide showing the amino acid sequence and cysteine disulfide bonds (S-S) that form the peptide's three-dimensional configuration.*

FDA Label Image

Principal Display Panelndc 0456-1203-30rx Only30 Capsuleslinzess(linaclotide) Capsules72 Mcg/capsuleattention Pharmacist:each Patient Is Required To Receivethe Enclosed Medication Guide.keep Linzess In The Original Containerto Protect From Moisture. Do Not Removethe Desiccant From Inside The Bottle. (Linzess 02)

Label for Linzess (linaclotide) capsules, gelatin-coated, 72 mcg strength, supplied in a bottle containing 30 capsules. The label includes storage instructions, pharmacist attention notice, and distributor and marketer information listing Allergan USA, Inc. and Ironwood Pharmaceuticals, Inc.*

FDA Label Image

Principal Display Panelndc 0456-1201-30rx Only30 Capsuleslinzess(linaclotide) Capsules145 Mcg/capsuleattention Pharmacist:each Patient Is Required To Receivethe Enclosed Medication Guide.keep Linzess In The Original Containerto Protect From Moisture. Do Not Removethe Desiccant From Inside The Bottle. (Linzess 03)

Label for Linzess (linaclotide) capsules, gelatin coated, 145 mcg strength, in a 30-capsule package. The label includes storage instructions, dosing notice of one capsule once daily, and distributor information for Allergan USA, Inc. The label also advises pharmacists to provide the enclosed Medication Guide.*

FDA Label Image

Principal Display Panelndc 0456-1202-30rx Only30 Capsuleslinzess(linaclotide) Capsules290 Mcg/capsuleattention Pharmacist:each Patient Is Required To Receivethe Enclosed Medication Guide.keep Linzess In The Original Containerto Protect From Moisture. Do Not Removethe Desiccant From Inside The Bottle. (Linzess 04)

Label for Linzess (linaclotide) capsules, gelatin coated, 290 mcg strength, oral route. The label indicates a package of 30 capsules with an NDC of 0456-1202-30. It includes storage instructions, dosing guidance, and pharmacist attention notes. Distributed by Allergan USA, Inc., and marketed by Ironwood Pharmaceuticals, Inc. and Allergan USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.